Vasodilatory effects of B-type natriuretic peptide are impaired in patients with chronic heart failure

This publication has 25 references indexed in Scilit:

• Differing Metabolism and Bioactivity of Atrial and Brain Natriuretic Peptides in Essential Hypertension
  Hypertension, 1996
• Atrial Natriuretic Peptide Suppresses the Transcription of Its Guanylyl Cyclase-linked Receptor
  Journal of Biological Chemistry, 1995
• Pulmonary vasorelaxant activity of atrial natriuretic peptide and brain natriuretic peptide in humans.
  Thorax, 1995
• Biological effects of rat iso-atrial natriuretic peptide and brain natriuretic peptide are indistinguishable from each other
  Canadian Journal of Physiology and Pharmacology, 1992
• Maintenance of forearm vasodilator action of atrial natriuretic factor in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy
  The American Journal of Cardiology, 1992
• Down-regulation of atrial natriuretic factor receptors and correlation with cGMP stimulation in rat cultured vascular smooth muscle cells
  Biochemical and Biophysical Research Communications, 1987
• Regulation of Guanylate Cyclase by Atrial Natriuretic Factor and the Role of Cyclic GMP in Vasodilation
  The Lancet Healthy Longevity, 1987
• Atrial Natriuretic Peptide and Atrial Pressure in Patients with Congestive Heart Failure
  New England Journal of Medicine, 1986
• Metabolic clearance rate and plasma half life of alpha-human atrial natriuretic peptide in man
  Life Sciences, 1986
• Atrial Natriuretic Peptide Elevation in Congestive Heart Failure in the Human
  Science, 1986